And given all the growing talk about the damage done to longterm health and immunity by excessive reliance on antibiotics, this looks like the way to go.
Printable View
And given all the growing talk about the damage done to longterm health and immunity by excessive reliance on antibiotics, this looks like the way to go.
I too am enthused by the potential for BLT (and am currently sitting on a nice 58% gain for less than 2 yrs holding) however, I suspect much future worth depends on the new CEO proving worthy of his title in the new-year. It's an exciting career move for the right person.
Anyone who wants lots of detail on the studies being done in BOP, Porrirua and Kawerau you should check the following document out. It is interesting reading!
https://www.google.co.nz/url?sa=t&rc...08194040,d.dGY
The following is old but provides some context around GAS, ARF, and RHD:
http://www.hrc.govt.nz/news-and-medi...-funding-boost
I don't normally focus on the softer more human aspects of investing in my posts but when I think RHD knocks 14 years off Maori men's lives, Blis K12 contributing to the solution would be fantastic, and looks like a like outcome in the short(possibly)/medium/long term.
I like this line
"If effective, this strategy could be incorporated immediately into the prevention of GAS sore throat occurring in all high risk populations in New Zealand". But will they do it? or piss around for another 10 years costing the country money and ruining people health? The cost/danger with getting kids to take Blis K12 is small, the result of inaction is tens of millions wasted on treating preventable heart problems. It seems like a no brainer, but then it has for a long time.
Budget for the trial was about $66K, BlisK12 cost $4k of that.
I always thought that the link was between peridontal diseases (gum disease) and heart disease. I also thought that peridontal disease and gum inflammation could also be a catalysing factor in other conditions. If BLT has products to counteract that, it would be great. DYOR.